Skip to main content
Erschienen in: Supportive Care in Cancer 9/2012

01.09.2012 | Short Communication

Emergency department cancer unit and management of oncologic emergencies: experience in Asan Medical Center

verfasst von: Shin Ahn, Yoon-Seon Lee, Kyung Soo Lim, Jae-Lyun Lee

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

With the increasing incidence of cancer patients, our institute set up an emergency department (ED) unit for cancer (cancer emergency room, CER). We intended to clarify the operating characteristics and administrative benefits of the CER.

Methods

The CER was opened in May 2009. Retrospective review of all patients managed in the CER from January 2010 to December 2010 was performed, and data of the patients during January 2008 to December 2008 were collected to compare the care before and after the introduction of the CER.

Results

A total of 5,502 cancer patients visited the CER during 2010; 88.8 % had solid tumor and 11.2 % had hematologic malignancies. Diagnosis was grouped into four categories: disease progression (55.5 %), infection (22.8 %), treatment-related complications (14.7 %), and noncancer-related problems (7 %). Common treatments included antibiotic administration (28.9 %), pain control (22.9 %), and drainage procedures (16.2 %). Of the 5,502 patients, 52.7 % were discharged, 0.2 % died during the stay, home service was supplied to 0.6 % for palliative care, and 4.5 % were transferred to other hospitals including hospice care center. When compared with the year 2008, inpatient unit admission decreased, cost of care in both ED and inpatient unit was reduced (all P values <0.05). However, length of stay in ED and inpatient unit was not different.

Conclusion

ED unit for cancer has a valuable role in managing patients with cancers, not only progression of disease but also various toxicities related to its treatments.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Adelberg DE, Bishop MR (2009) Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantation. Emerg Med Clin North Am 27(2):311–331PubMedCrossRef Adelberg DE, Bishop MR (2009) Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantation. Emerg Med Clin North Am 27(2):311–331PubMedCrossRef
2.
Zurück zum Zitat Jung KW, Park S, Won YJ, Kong HJ, Lee JY, Park EC, Lee JS (2011) Prediction of cancer incidence and mortality in Korea, 2011. Cancer Res Treat 43(1):12–18PubMedCrossRef Jung KW, Park S, Won YJ, Kong HJ, Lee JY, Park EC, Lee JS (2011) Prediction of cancer incidence and mortality in Korea, 2011. Cancer Res Treat 43(1):12–18PubMedCrossRef
3.
Zurück zum Zitat Brillman J, Mathers-Dunbar L, Graff L, Joseph T, Leikin JB, Schultz C, Severance HW Jr, Werne C (1995) Management of observation units. American College of Emergency Physicians. Ann Emerg Med 25(6):823–830PubMedCrossRef Brillman J, Mathers-Dunbar L, Graff L, Joseph T, Leikin JB, Schultz C, Severance HW Jr, Werne C (1995) Management of observation units. American College of Emergency Physicians. Ann Emerg Med 25(6):823–830PubMedCrossRef
4.
Zurück zum Zitat Daly S, Campbell DA, Cameron PA (2003) Short-stay units and observation medicine: a systematic review. Med J Aust 178(11):559–563PubMed Daly S, Campbell DA, Cameron PA (2003) Short-stay units and observation medicine: a systematic review. Med J Aust 178(11):559–563PubMed
5.
Zurück zum Zitat Martinez E, Reilly BM, Evans AT, Roberts RR (2001) The observation unit: a new interface between inpatient and outpatient care. Am J Med 110(4):274–277PubMedCrossRef Martinez E, Reilly BM, Evans AT, Roberts RR (2001) The observation unit: a new interface between inpatient and outpatient care. Am J Med 110(4):274–277PubMedCrossRef
6.
Zurück zum Zitat Majem M, Galan M, Perez FJ, Munoz M, Chicote S, Soler G, Navarro M, Martinez-Villacampa M, Garcia del Muro X, Dotor E, Laquente B, Germa JR (2007) The oncology acute toxicity unit (OATU): an outpatient facility for improving the management of chemotherapy toxicity. Clin Transl Oncol 9(12):784–788PubMedCrossRef Majem M, Galan M, Perez FJ, Munoz M, Chicote S, Soler G, Navarro M, Martinez-Villacampa M, Garcia del Muro X, Dotor E, Laquente B, Germa JR (2007) The oncology acute toxicity unit (OATU): an outpatient facility for improving the management of chemotherapy toxicity. Clin Transl Oncol 9(12):784–788PubMedCrossRef
8.
Zurück zum Zitat Beckett DJ, Raby E, Pal S, Jamdar R, Selby C (2009) Improvement in time to treatment following establishment of a dedicated medical admissions unit. Emerg Med J 26(12):878–880PubMedCrossRef Beckett DJ, Raby E, Pal S, Jamdar R, Selby C (2009) Improvement in time to treatment following establishment of a dedicated medical admissions unit. Emerg Med J 26(12):878–880PubMedCrossRef
9.
10.
Zurück zum Zitat Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34(6):730–751PubMedCrossRef Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34(6):730–751PubMedCrossRef
Metadaten
Titel
Emergency department cancer unit and management of oncologic emergencies: experience in Asan Medical Center
verfasst von
Shin Ahn
Yoon-Seon Lee
Kyung Soo Lim
Jae-Lyun Lee
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1478-8

Weitere Artikel der Ausgabe 9/2012

Supportive Care in Cancer 9/2012 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.